Vancomycin-resistant enterococci

Common Name(s)

Vancomycin-resistant enterococci, VRE, Enterococcus species resistant to vancomycin

VRE (Vancomycin-resistant Enterococcus) is an infection caused by the bacteria Enterococcus which has become resistant to treatment with vancomycin, an antibiotic commonly used to treat this type of infection. Enterococcus is a type of bacteria that is normally found in human intestines (gut) and the female genital tract and is also often found in the environment without causing disease. When it becomes resistant to vancomycin, it is then called vancomycin resistant Enterococcus or VRE. VRE can be present in an individual but not cause symptoms, this is often called colonization of the bacteria. Sometimes however, the VRE bacteria can cause a variety of infections in the urinary tract, the bloodstream or in open wounds on the skin. VRE is spread by simple skin to skin contact or by touching surfaces contaminated with the bacteria. Most VRE infections spread this way in hospitals. VRE cannot be spread through the air by coughing or sneezing. People at risk for VRE infections include those who have been previously treated with vancomycin or have had other long term antibiotic use, people with weakened immune systems especially in the hospital setting, surgical patients, or people with urinary catheters or intravenous tubing placed (IV) as these allow an opening for the bacteria to enter the body.

To avoid the spread of VRE, wash hands frequently and hospital workers or care givers should wear gown and gloves when treating an infected person. Individuals with colonized bacteria (no symptoms) do not need to be treated. Most VRE infections can be treated with antibiotics other than vancomycin. Lab tests can determine which antibiotics may work best. If you think you may have VRE or may have been exposed, speak with your doctor. If you have been diagnosed with VRE, talk with your doctor or specialist about the most current treatment options.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Vancomycin-resistant enterococci" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Vancomycin-resistant enterococci" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Vancomycin-resistant enterococci" returned 199 free, full-text research articles on human participants. First 3 results:

Emergence of Vancomycin-resistant Enterococci at a Teaching Hospital, Saudi Arabia.
 

Author(s): Fawzia E Alotaibi, Elham E Bukhari

Journal: Chin. Med. J.. 2017 02;130(3):340-346.

 

Vancomycin-resistant enterococci (VRE) are a major and emerging hospital-acquired pathogen associated with high mortality, particularly among the critically ill and Intensive Care Units (ICUs) patients. This study aimed to determine the prevalence and demographic and clinical characteristics ...

Last Updated: 31 Jan 2017

Go To URL
Vancomycin-resistant enterococci in neonatal stool as a cause of septicemia: Challenges for infection control practices.
 

Author(s): Satyendra Kaushal, Tuhina Banerjee, Shampa Anupurba, Ashok Kumar

Journal: Indian J Pathol Microbiol. ;59(4):548-550.

 

The increasing reports of vancomycin-resistant enterococci (VRE) as a cause of neonatal septicemia are of recent interest. However, in majority of the cases, the source of VRE could not be located. As a consequence, the real importance of VRE and its control measures is undermined. ...

Last Updated: 10 Oct 2016

Go To URL
Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.
 

Author(s): N Monteserin, E Larson

Journal: J. Hosp. Infect.. 2016 Nov;94(3):236-241.

 

Published data regarding temporal trends in vancomycin-resistant enterococci (VRE) prevalence within specific regions or healthcare systems are scarce.

Last Updated: 26 Sep 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Vancomycin-resistant enterococci" returned 13 free, full-text review articles on human participants. First 3 results:

Daptomycin for the treatment of bacteraemia due to vancomycin-resistant enterococci.
 

Author(s): Jose M Munita, Barbara E Murray, Cesar A Arias

Journal: Int. J. Antimicrob. Agents. 2014 Nov;44(5):387-95.

 

Treatment of severe infections caused by vancomycin-resistant enterococci (VRE) is challenging due to the scarcity of reliable therapeutic alternatives. In this context, daptomycin (DAP), a lipopeptide antibiotic, has emerged as an interesting alternative as it is one of the few compounds ...

Last Updated: 2 Dec 2014

Go To URL
Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literature.
 

Author(s): Jeffrey S Wang, Katie Muzevich, Michael B Edmond, Gonzalo Bearman, Michael P Stevens

Journal: Int. J. Infect. Dis.. 2014 Aug;25():26-31.

 

To evaluate reported cases of central nervous system (CNS) infections due to vancomycin-resistant enterococci (VRE) and describe the data necessary to better understand clinical characteristics of this rare disease process.

Last Updated: 23 Jul 2014

Go To URL
Vancomycin resistant enterococci healthcare associated infections.
 

Author(s): G B Orsi, V Ciorba

Journal: Ann Ig. ;25(6):485-92.

 

Vancomycin-resistant enterococci (VRE) are among the most common healthcare associated multidrug-resistant organisms. Purpose of the article was to review recent data regarding the epidemiology, clinical issues and infection control of this organisms.

Last Updated: 28 Nov 2013

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Theraworx Bath Wipes Versus Standard Bath Wipes in the Reduction of Vancomycin-Resistant Enterococci
 

Status: Recruiting

Condition Summary: Hematopoietic Stem Cell Transplantation; Vancomycin-Resistant Enterococci

 

Last Updated: 31 Mar 2017

Go to URL
A Trial of Encapsulated Fecal Microbiota for Vancomycin Resistant Enterococcus Decolonization
 

Status: Not yet recruiting

Condition Summary: Antibiotic Resistant Strain

 

Last Updated: 21 Feb 2017

Go to URL
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
 

Status: Recruiting

Condition Summary: Clostridium Difficile Infection; VRE Infection; Nosocomial Infection; MRGN Bacteria

 

Last Updated: 14 Aug 2017

Go to URL